Interaction between Neurotensin and Dopamine in the Brain
Identifieur interne : 000B50 ( Istex/Corpus ); précédent : 000B49; suivant : 000B51Interaction between Neurotensin and Dopamine in the Brain
Auteurs : William Rostène ; Aline Brouard ; Corinne Dana ; Yoshinori Masuo ; France Agid ; Micheline Vial ; Anne-Marie Lhiaubet ; Didier PelapratSource :
- Annals of the New York Academy of Sciences [ 0077-8923 ] ; 1992-10.
Url:
DOI: 10.1111/j.1749-6632.1992.tb27352.x
Links to Exploration step
ISTEX:135BE6F1E74ADD9674480F68A24875253FBBEC94Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interaction between Neurotensin and Dopamine in the Brain</title>
<author><name sortKey="Rostene, William" sort="Rostene, William" uniqKey="Rostene W" first="William" last="Rostène">William Rostène</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Address for correspondence: INSERM U.339, Hǒpital Saint‐antoine, 184, rue du Fg. St. Antoine, 75571 Paris Cedex 12, France.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brouard, Aline" sort="Brouard, Aline" uniqKey="Brouard A" first="Aline" last="Brouard">Aline Brouard</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Dana, Corinne" sort="Dana, Corinne" uniqKey="Dana C" first="Corinne" last="Dana">Corinne Dana</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Masuo, Yoshinori" sort="Masuo, Yoshinori" uniqKey="Masuo Y" first="Yoshinori" last="Masuo">Yoshinori Masuo</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Agid, France" sort="Agid, France" uniqKey="Agid F" first="France" last="Agid">France Agid</name>
<affiliation><mods:affiliation>INSERM U.289, Hǒpital de la Salpétrière, 75651 Paris Cedex 13, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Vial, Micheline" sort="Vial, Micheline" uniqKey="Vial M" first="Micheline" last="Vial">Micheline Vial</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Lhiaubet, Anne Arie" sort="Lhiaubet, Anne Arie" uniqKey="Lhiaubet A" first="Anne-Marie" last="Lhiaubet">Anne-Marie Lhiaubet</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pelaprat, Didier" sort="Pelaprat, Didier" uniqKey="Pelaprat D" first="Didier" last="Pelaprat">Didier Pelaprat</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:135BE6F1E74ADD9674480F68A24875253FBBEC94</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1111/j.1749-6632.1992.tb27352.x</idno>
<idno type="url">https://api.istex.fr/document/135BE6F1E74ADD9674480F68A24875253FBBEC94/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B50</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B50</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Interaction between Neurotensin and Dopamine in the Brain</title>
<author><name sortKey="Rostene, William" sort="Rostene, William" uniqKey="Rostene W" first="William" last="Rostène">William Rostène</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Address for correspondence: INSERM U.339, Hǒpital Saint‐antoine, 184, rue du Fg. St. Antoine, 75571 Paris Cedex 12, France.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Brouard, Aline" sort="Brouard, Aline" uniqKey="Brouard A" first="Aline" last="Brouard">Aline Brouard</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Dana, Corinne" sort="Dana, Corinne" uniqKey="Dana C" first="Corinne" last="Dana">Corinne Dana</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Masuo, Yoshinori" sort="Masuo, Yoshinori" uniqKey="Masuo Y" first="Yoshinori" last="Masuo">Yoshinori Masuo</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Agid, France" sort="Agid, France" uniqKey="Agid F" first="France" last="Agid">France Agid</name>
<affiliation><mods:affiliation>INSERM U.289, Hǒpital de la Salpétrière, 75651 Paris Cedex 13, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Vial, Micheline" sort="Vial, Micheline" uniqKey="Vial M" first="Micheline" last="Vial">Micheline Vial</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Lhiaubet, Anne Arie" sort="Lhiaubet, Anne Arie" uniqKey="Lhiaubet A" first="Anne-Marie" last="Lhiaubet">Anne-Marie Lhiaubet</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pelaprat, Didier" sort="Pelaprat, Didier" uniqKey="Pelaprat D" first="Didier" last="Pelaprat">Didier Pelaprat</name>
<affiliation><mods:affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of the New York Academy of Sciences</title>
<idno type="ISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<imprint><publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1992-10">1992-10</date>
<biblScope unit="volume">668</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="217">217</biblScope>
<biblScope unit="page" to="231">231</biblScope>
</imprint>
<idno type="ISSN">0077-8923</idno>
</series>
<idno type="istex">135BE6F1E74ADD9674480F68A24875253FBBEC94</idno>
<idno type="DOI">10.1111/j.1749-6632.1992.tb27352.x</idno>
<idno type="ArticleID">NYAS217</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0077-8923</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>WILLIAM ROSTÈNE</name>
<affiliations><json:string>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</json:string>
<json:string>Address for correspondence: INSERM U.339, Hǒpital Saint‐antoine, 184, rue du Fg. St. Antoine, 75571 Paris Cedex 12, France.</json:string>
</affiliations>
</json:item>
<json:item><name>ALINE BROUARD</name>
<affiliations><json:string>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</json:string>
</affiliations>
</json:item>
<json:item><name>CORINNE DANA</name>
<affiliations><json:string>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</json:string>
</affiliations>
</json:item>
<json:item><name>YOSHINORI MASUO</name>
<affiliations><json:string>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</json:string>
</affiliations>
</json:item>
<json:item><name>FRANCE AGID</name>
<affiliations><json:string>INSERM U.289, Hǒpital de la Salpétrière, 75651 Paris Cedex 13, France</json:string>
</affiliations>
</json:item>
<json:item><name>MICHELINE VIAL</name>
<affiliations><json:string>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</json:string>
</affiliations>
</json:item>
<json:item><name>ANNE‐MARIE LHIAUBET</name>
<affiliations><json:string>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</json:string>
</affiliations>
</json:item>
<json:item><name>DIDIER PELAPRAT</name>
<affiliations><json:string>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>NYAS217</json:string>
</articleId>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>article</json:string>
</originalGenre>
<qualityIndicators><score>5.337</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>414 x 648 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>4825</pdfWordCount>
<pdfCharCount>31490</pdfCharCount>
<pdfPageCount>15</pdfPageCount>
<abstractWordCount>1</abstractWordCount>
</qualityIndicators>
<title>Interaction between Neurotensin and Dopamine in the Brain</title>
<refBibs><json:item><author><json:item><name>P. J. Elliot</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
</author>
<host><pages><last>245</last>
<first>219</first>
</pages>
<author></author>
<title>Neural and Endocrine Peptides and Receptors</title>
</host>
<title>The neurobiology of neurotensin</title>
</json:item>
<json:item><author><json:item><name>P. W. Kalivas</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
<json:item><name>J. S. Miller</name>
</json:item>
<json:item><name>A. J. Prange Jr.</name>
</json:item>
</author>
<host><volume>326</volume>
<pages><last>227</last>
<first>219</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Microinjection of neurotensin into ventral tegmental area produces hypothermia: Evaluation of dopamine mediation</title>
</json:item>
<json:item><author><json:item><name>G. N. Ewin</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
</author>
<host><volume>12</volume>
<pages><last>569</last>
<first>553</first>
</pages>
<author></author>
<title>Prog. Neuropsychopharmacol. Biol. Psychiatry</title>
</host>
<title>Interactions of neurotensin with dopamine‐containing neurons in the central nervous system</title>
</json:item>
<json:item><author><json:item><name>J. A. Garcia‐Sevilla</name>
</json:item>
<json:item><name>T. Magnusson</name>
</json:item>
<json:item><name>A. Carlsson</name>
</json:item>
<json:item><name>J. Leban</name>
</json:item>
<json:item><name>K. Folkers</name>
</json:item>
</author>
<host><volume>305</volume>
<pages><last>218</last>
<first>213</first>
</pages>
<author></author>
<title>Naunyn Schmiedeberg's Arch. Pharmcaol.</title>
</host>
<title>Neurotensin and its amide analogue (Gln4)‐neurotensin: Effects on brain monamine turnover</title>
</json:item>
<json:item><author><json:item><name>E. Widerlov</name>
</json:item>
<json:item><name>C. D. Kilts</name>
</json:item>
<json:item><name>R. B. Mailman</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
<json:item><name>A. J. Prange Jr.</name>
</json:item>
<json:item><name>G. R. Breese</name>
</json:item>
</author>
<host><volume>222</volume>
<pages><last>6</last>
<first>1</first>
</pages>
<author></author>
<title>J. Pharmacol. Exp. Ther.</title>
</host>
<title>Increase in dopamine metabolites in rat brain by neurotensin</title>
</json:item>
<json:item><author><json:item><name>M. Ruggeri</name>
</json:item>
<json:item><name>U. Ungerstedt</name>
</json:item>
<json:item><name>L. F. Agnati</name>
</json:item>
<json:item><name>V. Mutt</name>
</json:item>
<json:item><name>A. Harfstrand</name>
</json:item>
<json:item><name>K. Fuxe</name>
</json:item>
</author>
<host><volume>10</volume>
<pages><last>520</last>
<first>509</first>
</pages>
<author></author>
<title>Neurochem. Int.</title>
</host>
<title>Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of nucleus accumbens using intracerebral dialysis in the anaesthetized rat</title>
</json:item>
<json:item><author><json:item><name>P. W. Kalivas</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
<json:item><name>A. J. Prange Jr.</name>
</json:item>
</author>
<host><volume>400</volume>
<pages><last>318</last>
<first>307</first>
</pages>
<author></author>
<title>Ann. N. Y. Acad. Sci.</title>
</host>
<title>Neuroanatomical sites of action of neurotensin</title>
</json:item>
<json:item><author><json:item><name>R. D. Myers</name>
</json:item>
<json:item><name>T. F. Lee</name>
</json:item>
</author>
<host><volume>4</volume>
<pages><last>961</last>
<first>955</first>
</pages>
<author></author>
<title>In vivo release of dopamine during perfusion of neurotensin in substantia nigra of the unrestrained rat. Peptides</title>
</host>
<title>1983</title>
</json:item>
<json:item><author><json:item><name>M. Goedert</name>
</json:item>
<json:item><name>S. D. Iversen</name>
</json:item>
<json:item><name>P. C. Emson</name>
</json:item>
</author>
<host><volume>335</volume>
<pages><last>336</last>
<first>334</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>The effects of chronic neuroleptic treatment on neurotensin‐like immunoreactivity in the rat central nervous system</title>
</json:item>
<json:item><author><json:item><name>Y. Masuo</name>
</json:item>
<json:item><name>D. Pélaprat</name>
</json:item>
<json:item><name>M. N. Montagne</name>
</json:item>
<json:item><name>D. Scherman</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
</author>
<host><volume>510</volume>
<pages><last>210</last>
<first>203</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Regulation of neurotensin‐containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6‐hydroxydopamine on neurotensin content and its binding site density</title>
</json:item>
<json:item><author><json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>F. Checler</name>
</json:item>
<json:item><name>J. Mazella</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
</author>
<host><volume>5</volume>
<pages><last>486</last>
<first>397</first>
</pages>
<author></author>
<title>Rev. Basic Clin. Pharmacol.</title>
</host>
<title>Pharmacology and biochemistry of neurotensin receptors</title>
</json:item>
<json:item><author><json:item><name>W. S. Young III</name>
</json:item>
<json:item><name>M. J. Kuhar</name>
</json:item>
</author>
<host><volume>59</volume>
<pages><last>163</last>
<first>161</first>
</pages>
<author></author>
<title>Eur. J. Pharmacol.</title>
</host>
<title>Neurotensin receptors: Autoradiographic localization in rat CNS</title>
</json:item>
<json:item><author><json:item><name>R. Quirion</name>
</json:item>
<json:item><name>C. C. Chiueh</name>
</json:item>
<json:item><name>H. D. Everist</name>
</json:item>
<json:item><name>A. Pert</name>
</json:item>
</author>
<host><volume>327</volume>
<pages><last>389</last>
<first>385</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals</title>
</json:item>
<json:item><author><json:item><name>A. Sarrieau</name>
</json:item>
<json:item><name>F. Javoy‐Agid</name>
</json:item>
<json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>M. Dussaillant</name>
</json:item>
<json:item><name>M. Vial</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
<json:item><name>Y. Agid</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
</author>
<host><volume>348</volume>
<pages><last>380</last>
<first>375</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Characterization and autoradiographic distribution of neurotensin binding sites in the human brain</title>
</json:item>
<json:item><author><json:item><name>G. Chinaglia</name>
</json:item>
<json:item><name>A. Probst</name>
</json:item>
<json:item><name>J. M. Palacios</name>
</json:item>
</author>
<host><volume>39</volume>
<pages><last>360</last>
<first>351</first>
</pages>
<author></author>
<title>Neuro-science</title>
</host>
<title>Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy: An autoradiographic study in basal ganglia</title>
</json:item>
<json:item><author><json:item><name>T. Hökfelt</name>
</json:item>
<json:item><name>B. J. Everitt</name>
</json:item>
<json:item><name>E. Theodorsson‐Norheim</name>
</json:item>
<json:item><name>M. Goldstein</name>
</json:item>
</author>
<host><volume>222</volume>
<pages><last>559</last>
<first>543</first>
</pages>
<author></author>
<title>J. Comp. Neurol.</title>
</host>
<title>Occurrence of neurotensin‐like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons</title>
</json:item>
<json:item><author><json:item><name>K. Seroogy</name>
</json:item>
<json:item><name>S. Ceccatelli</name>
</json:item>
<json:item><name>M. Schalling</name>
</json:item>
<json:item><name>T. Hökfelt</name>
</json:item>
<json:item><name>P. Frey</name>
</json:item>
<json:item><name>J. Walsh</name>
</json:item>
<json:item><name>G. Dockray</name>
</json:item>
<json:item><name>J. Brown</name>
</json:item>
<json:item><name>A. Buchan</name>
</json:item>
<json:item><name>M. Goldstein</name>
</json:item>
</author>
<host><volume>455</volume>
<pages><last>89</last>
<first>88</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>A subpopulation of dopaminergic neurons in rat ventral mesencephalon contain both neurotensin and cholecystokinin</title>
</json:item>
<json:item><author><json:item><name>J. Mai</name>
</json:item>
<json:item><name>K. J. Triepel</name>
</json:item>
<json:item><name>J. Metz</name>
</json:item>
</author>
<host><volume>22</volume>
<pages><last>524</last>
<first>499</first>
</pages>
<author></author>
<title>Neuroscience</title>
</host>
<title>Neurotensin in the human brain</title>
</json:item>
<json:item><author><json:item><name>J. Woulfe</name>
</json:item>
<json:item><name>A. Beaudet</name>
</json:item>
</author>
<host><volume>479</volume>
<pages><last>406</last>
<first>402</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Immunocytochemical evidence for direct connections between NT‐containing axons and dopaminergic neurons in the rat ventral midbrain tegmentum</title>
</json:item>
<json:item><author><json:item><name>D. S. Zahm</name>
</json:item>
</author>
<host><volume>81</volume>
<pages><last>47</last>
<first>41</first>
</pages>
<author></author>
<title>Neurosci. Lett.</title>
</host>
<title>Neurotensin‐immunoreactive neurons in the ventral striatum of the adult rat: Ventromedial caudate‐putamen, nucleus accumbens and olfactory tubercle</title>
</json:item>
<json:item><author><json:item><name>L. Jennes</name>
</json:item>
<json:item><name>W. E. Stumpf</name>
</json:item>
<json:item><name>P. W. Kalivas</name>
</json:item>
</author>
<host><volume>210</volume>
<pages><last>224</last>
<first>211</first>
</pages>
<author></author>
<title>J. Comp. Neurol.</title>
</host>
<title>Neurotensin: Topographical distribution in rat brain by immunohistochemistry</title>
</json:item>
<json:item><author><json:item><name>P. C. Emson</name>
</json:item>
<json:item><name>M. Goedert</name>
</json:item>
<json:item><name>P. W. Mantyh</name>
</json:item>
</author>
<host><volume>4</volume>
<pages><last>405</last>
<first>355</first>
</pages>
<author></author>
<title>Hand‐book of Chemical Neuroanatomy: GABA and Neuropeptides in the CNS</title>
</host>
<title>Neurotensin‐containing neurons</title>
</json:item>
<json:item><author><json:item><name>J. M. Studler</name>
</json:item>
<json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>G. Tramu</name>
</json:item>
<json:item><name>D. Hervé</name>
</json:item>
<json:item><name>J. Glowinski</name>
</json:item>
<json:item><name>J. P. Tassin</name>
</json:item>
</author>
<host><volume>11</volume>
<pages><last>100</last>
<first>95</first>
</pages>
<author></author>
<title>Neuropeptides</title>
</host>
<title>Extensive co‐localisation of neurotensin with dopamine in rat meso‐cortico‐frontal dopaminergic neurons</title>
</json:item>
<json:item><author><json:item><name>E. Moyse</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
<json:item><name>M. Vial</name>
</json:item>
<json:item><name>K. Leonard</name>
</json:item>
<json:item><name>J. Mazella</name>
</json:item>
<json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
<json:item><name>A. Beaudet</name>
</json:item>
</author>
<host><volume>22</volume>
<pages><last>536</last>
<first>525</first>
</pages>
<author></author>
<title>Neuroscience</title>
</host>
<title>Distribution of neurotensin binding sites in rat brain: A light microscopic radioautographic study using monoiodo 125I‐Tyr3‐neurotensin</title>
</json:item>
<json:item><author><json:item><name>E. Szigethy</name>
</json:item>
<json:item><name>A. Beaudet</name>
</json:item>
</author>
<host><volume>279</volume>
<pages><last>137</last>
<first>128</first>
</pages>
<author></author>
<title>J. Comp. Neurol.</title>
</host>
<title>Correspondence between high affinity 125I‐neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area. A combined radioautographic and immunocytochemical light microscopic study</title>
</json:item>
<json:item><author><json:item><name>O. Lindvall</name>
</json:item>
<json:item><name>A. Björklund</name>
</json:item>
</author>
<host><volume>10</volume>
<pages><last>40</last>
<first>9</first>
</pages>
<author></author>
<title>Neurological Neurobiology, Monoamine innervation of Cerebral Cortex</title>
</host>
<title>General organization of cortical monoamine systems</title>
</json:item>
<json:item><author><json:item><name>J. M. Palacios</name>
</json:item>
<json:item><name>M. J. Kuhar</name>
</json:item>
</author>
<host><volume>294</volume>
<pages><last>589</last>
<first>587</first>
</pages>
<author></author>
<title>Nature</title>
</host>
<title>Neurotensin receptors are located on dopamine‐containing neurons in rat midbrain</title>
</json:item>
<json:item><author><json:item><name>D. Hervé</name>
</json:item>
<json:item><name>J. P. Tassin</name>
</json:item>
<json:item><name>J. M. Studler</name>
</json:item>
<json:item><name>C. Dana</name>
</json:item>
<json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
<json:item><name>J. Glowinski</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
</author>
<host><volume>83</volume>
<pages><last>6207</last>
<first>6203</first>
</pages>
<author></author>
<title>Proc. Natl. Acad. Sci. USA</title>
</host>
<title>Dopaminergic control of 125I‐labeled neurotensin binding site density in corticolimbic structures of the rat brain</title>
</json:item>
<json:item><author><json:item><name>C. Dana</name>
</json:item>
<json:item><name>M. Vial</name>
</json:item>
<json:item><name>K. Leonard</name>
</json:item>
<json:item><name>A. Beauregard</name>
</json:item>
<json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
<json:item><name>V. Rostène</name>
</json:item>
<json:item><name>A. Beaudet</name>
</json:item>
</author>
<host><volume>9</volume>
<pages><last>2257</last>
<first>2247</first>
</pages>
<author></author>
<title>J. Neurosci.</title>
</host>
<title>Electron microscopic localization of neurotensin binding sites in the midbrain tegmentum of the rat. I. Ventral tegmental area and inerfascicular nucleus</title>
</json:item>
<json:item><author><json:item><name>C. Dana</name>
</json:item>
<json:item><name>D. Pélaprat</name>
</json:item>
<json:item><name>M. Vial</name>
</json:item>
<json:item><name>A. Brouard</name>
</json:item>
<json:item><name>A. M. Lhiaubet</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
</author>
<host><volume>61</volume>
<pages><last>264</last>
<first>259</first>
</pages>
<author></author>
<title>Dev. Brain Res.</title>
</host>
<title>Characterization of neurotensin binding sites on rat mesencephalic cells in primary culture</title>
</json:item>
<json:item><author><json:item><name>A. Schotte</name>
</json:item>
<json:item><name>W. Rosténe</name>
</json:item>
<json:item><name>P. M. Laduron</name>
</json:item>
</author>
<host><volume>333</volume>
<pages><last>405</last>
<first>400</first>
</pages>
<author></author>
<title>Naunyn-Schmiedeberg's Arch. Pharmacol.</title>
</host>
<title>Evidence for a displacable nonspecific [3H]neurotensin binding site in rat brain</title>
</json:item>
<json:item><author><json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
<json:item><name>M. Dussaillant</name>
</json:item>
<json:item><name>A. Schotte</name>
</json:item>
<json:item><name>P. M. Laduron</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
</author>
<host><volume>140</volume>
<pages><last>293</last>
<first>285</first>
</pages>
<author></author>
<title>Eur. J. Pharmacol.</title>
</host>
<title>Two populations of neurotensin binding sites in murine brain: Discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution</title>
</json:item>
<json:item><author><json:item><name>A. Beaudet</name>
</json:item>
<json:item><name>E. Moyse</name>
</json:item>
<json:item><name>E. Szigethy</name>
</json:item>
<json:item><name>D. Marcel</name>
</json:item>
<json:item><name>K. Leonard</name>
</json:item>
<json:item><name>C. Dana</name>
</json:item>
<json:item><name>W. Rosténe</name>
</json:item>
</author>
<host><volume>Vol 53</volume>
<pages><last>115</last>
<first>103</first>
</pages>
<author></author>
<title>Visualization of Brain Functions</title>
</host>
<title>Association of neuropeptide receptors with central catecholaminergic neurons: Light and electronmicroscopic investigations</title>
</json:item>
<json:item><author><json:item><name>B. Berger</name>
</json:item>
<json:item><name>U. Di Porzio</name>
</json:item>
<json:item><name>M. C. Daguet</name>
</json:item>
<json:item><name>M. Gay</name>
</json:item>
<json:item><name>A. Vigny</name>
</json:item>
<json:item><name>J. Glowinski</name>
</json:item>
<json:item><name>A. Prochiantz</name>
</json:item>
</author>
<host><volume>7</volume>
<pages><last>205</last>
<first>193</first>
</pages>
<author></author>
<title>Neuro-science</title>
</host>
<title>Long‐term development of mesencephalic dopaminergic neurons of mouse embryos in dissociated primary culture: Morphological and histochemical characteristics</title>
</json:item>
<json:item><author><json:item><name>G. Barbin</name>
</json:item>
<json:item><name>M. Mallet</name>
</json:item>
<json:item><name>A. Prochiantz</name>
</json:item>
</author>
<host><volume>7</volume>
<pages><last>307</last>
<first>296</first>
</pages>
<author></author>
<title>Dev. Neurosci.</title>
</host>
<title>In vitro studies on the maturation of mesencephalic dopaminergic neurons</title>
</json:item>
<json:item><author><json:item><name>J. Engele</name>
</json:item>
<json:item><name>C. Pilgrim</name>
</json:item>
<json:item><name>M. Kirsch</name>
</json:item>
<json:item><name>I. Reisert</name>
</json:item>
</author>
<host><volume>483</volume>
<pages><last>109</last>
<first>98</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Different developmental potentials of diéncephalic and mesencephalic dopaminergic neurons in vitro</title>
</json:item>
<json:item><author><json:item><name>J. Chabry</name>
</json:item>
<json:item><name>F. Checler</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
<json:item><name>J. Mazella</name>
</json:item>
</author>
<host><volume>10</volume>
<pages><last>3921</last>
<first>3916</first>
</pages>
<author></author>
<title>J. Neurosci.</title>
</host>
<title>Colocalization of neurotensin receptors and of the neurotensin‐degrading enzyme endopeptidase 24–16 in primary cultures of neurons</title>
</json:item>
<json:item><author><json:item><name>R. D. Pinnock</name>
</json:item>
</author>
<host><volume>338</volume>
<pages><last>154</last>
<first>151</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Neurotensin depolarizes substantia nigra dopaminergic neurons</title>
</json:item>
<json:item><author><json:item><name>V. Seutin</name>
</json:item>
<json:item><name>L. Massotte</name>
</json:item>
<json:item><name>A. Dresse</name>
</json:item>
</author>
<host><volume>28</volume>
<pages><last>954</last>
<first>949</first>
</pages>
<author></author>
<title>Neuropharmacology</title>
</host>
<title>Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro</title>
</json:item>
<json:item><author><json:item><name>M. De Quidt</name>
</json:item>
<json:item><name>P. C. Emson</name>
</json:item>
</author>
<host><volume>274</volume>
<pages><last>380</last>
<first>376</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Neurotensin facilitates dopamine release in vitro from rat striatal slices</title>
</json:item>
<json:item><author><json:item><name>E. Hétier</name>
</json:item>
<json:item><name>A. Boireau</name>
</json:item>
<json:item><name>P. Dubedat</name>
</json:item>
<json:item><name>J. C. Blanchard</name>
</json:item>
</author>
<host><volume>337</volume>
<pages><last>17</last>
<first>13</first>
</pages>
<author></author>
<title>Naunyn Schmiedeberg's Arch. Pharmacol.</title>
</host>
<title>Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat</title>
</json:item>
<json:item><author><json:item><name>C. D. Blaha</name>
</json:item>
<json:item><name>A. Coury</name>
</json:item>
<json:item><name>H. C. Fibiger</name>
</json:item>
<json:item><name>A. G. Phillips</name>
</json:item>
</author>
<host><volume>34</volume>
<pages><last>705</last>
<first>699</first>
</pages>
<author></author>
<title>Neuroscience</title>
</host>
<title>Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: Cross‐validation using in vivo voltametry and microdialysis</title>
</json:item>
<json:item><author><json:item><name>P. W. Kalivas</name>
</json:item>
<json:item><name>S. K. Burgess</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
<json:item><name>A. J. Prange Jr.</name>
</json:item>
</author>
<host><volume>8</volume>
<pages><last>505</last>
<first>495</first>
</pages>
<author></author>
<title>Neuro-science</title>
</host>
<title>Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area</title>
</json:item>
<json:item><author><json:item><name>M. Cador</name>
</json:item>
<json:item><name>A. E. Kelley</name>
</json:item>
<json:item><name>M. Le Moal</name>
</json:item>
<json:item><name>L. Stinus</name>
</json:item>
</author>
<host><volume>85</volume>
<pages><last>196</last>
<first>187</first>
</pages>
<author></author>
<title>Psychopharmacology</title>
</host>
<title>Behavioral analysis of the effect of neurotensin injection into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat</title>
</json:item>
<json:item><author><json:item><name>W. Rostène</name>
</json:item>
<json:item><name>C. Mourre</name>
</json:item>
<json:item><name>M. N. Montagne</name>
</json:item>
<json:item><name>C. Dana</name>
</json:item>
<json:item><name>Z. Bouizar</name>
</json:item>
<json:item><name>A. Beaudet</name>
</json:item>
</author>
<host><volume>13</volume>
<pages><last>111</last>
<first>103</first>
</pages>
<author></author>
<title>Hormones and Cell Regulation</title>
</host>
<title>Visualization of central and peripheral hormonal receptors</title>
</json:item>
<json:item><author><json:item><name>M. J. Kuhar</name>
</json:item>
<json:item><name>J. R. Unnerstall</name>
</json:item>
</author>
<host><pages><last>218</last>
<first>177</first>
</pages>
<author></author>
<title>Methods in Neurotransmitter Receptor Analysis</title>
</host>
<title>Receptor autoradiography</title>
</json:item>
<json:item><author><json:item><name>A. Brouard</name>
</json:item>
<json:item><name>D. Pelaprat</name>
</json:item>
<json:item><name>C. Dana</name>
</json:item>
<json:item><name>M. Vial</name>
</json:item>
<json:item><name>A. M. Lhiaubet</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
</author>
<host><volume>12</volume>
<pages><last>1415</last>
<first>1409</first>
</pages>
<author></author>
<title>J. Neurosci.</title>
</host>
<title>Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors</title>
</json:item>
<json:item><author><json:item><name>S. Govini</name>
</json:item>
<json:item><name>J. S. Hong</name>
</json:item>
<json:item><name>H.‐Y. T. Yang</name>
</json:item>
<json:item><name>E. Costa</name>
</json:item>
</author>
<host><volume>215</volume>
<pages><last>417</last>
<first>413</first>
</pages>
<author></author>
<title>J. Pharmacol. Exp. Ther.</title>
</host>
<title>Increase of neurotensin content elicited by neuroleptics in nucleus accumbens</title>
</json:item>
<json:item><author><json:item><name>M. Goedert</name>
</json:item>
<json:item><name>S. D. Iversen</name>
</json:item>
<json:item><name>P. C. Emson</name>
</json:item>
</author>
<host><volume>335</volume>
<pages><last>336</last>
<first>334</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>The effects of chronic treatment on neurotensin‐like immunoreactivity in the rat central nervous system</title>
</json:item>
<json:item><author><json:item><name>P. Frey</name>
</json:item>
<json:item><name>K. Fuxe</name>
</json:item>
<json:item><name>P. Eneroth</name>
</json:item>
<json:item><name>L. F. Agnati</name>
</json:item>
</author>
<host><volume>8</volume>
<pages><last>434</last>
<first>429</first>
</pages>
<author></author>
<title>Neurochem. Int.</title>
</host>
<title>Effects of acute and long‐term treatment with neuroleptics on regional telencephalic neurotensin levels in the male rat</title>
</json:item>
<json:item><author><json:item><name>C. D. Kilts</name>
</json:item>
<json:item><name>C. M. Anderson</name>
</json:item>
<json:item><name>G. Bissette</name>
</json:item>
<json:item><name>T. D. Ely</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
</author>
<host><volume>37</volume>
<pages><last>1554</last>
<first>1547</first>
</pages>
<author></author>
<title>Biochem. Pharmacol.</title>
</host>
<title>Differential effects of antipsychotic drugs on neurotensin concentration of discrete rat brain nuclei</title>
</json:item>
<json:item><author><json:item><name>K. M. Merchant</name>
</json:item>
<json:item><name>M. A. Miller</name>
</json:item>
<json:item><name>E. A. Ashleigh</name>
</json:item>
<json:item><name>D. M. Dorsa</name>
</json:item>
</author>
<host><volume>540</volume>
<pages><last>314</last>
<first>311</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Haloperidol rapidly increases the number of neurotensin mRNA‐expressing neurons in neostriatum of the rat brain</title>
</json:item>
<json:item><author><json:item><name>K. W. Eggerman</name>
</json:item>
<json:item><name>D. S. Zahm</name>
</json:item>
</author>
<host><volume>11</volume>
<pages><last>132</last>
<first>125</first>
</pages>
<author></author>
<title>Neuropeptides</title>
</host>
<title>Numbers of neurotensin‐immunoreactive neurons selectively increased in rat ventral striatum following acute haloperidol administration</title>
</json:item>
<json:item><author><json:item><name>K. M. Merchant</name>
</json:item>
<json:item><name>J. W. Gibb</name>
</json:item>
<json:item><name>G. R. Hanson</name>
</json:item>
</author>
<host><volume>160</volume>
<pages><last>412</last>
<first>409</first>
</pages>
<author></author>
<title>Eur. J. Pharmacol.</title>
</host>
<title>Role of dopamine D‐1 and D‐2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens</title>
</json:item>
<json:item><author><json:item><name>D. S. Zahm</name>
</json:item>
<json:item><name>S. N. Johnson</name>
</json:item>
</author>
<host><volume>483</volume>
<pages><last>311</last>
<first>301</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Asymmetrical distribution of neurotensin immunoreactivity following unilateral injection of 6‐hydroxydopamine in rat ventral tegmental area (VTA)</title>
</json:item>
<json:item><author><json:item><name>S. J. Augood</name>
</json:item>
<json:item><name>H. Kiyama</name>
</json:item>
<json:item><name>R. L. M. Faull</name>
</json:item>
<json:item><name>P. C. Emson</name>
</json:item>
</author>
<host><volume>9</volume>
<pages><last>346</last>
<first>341</first>
</pages>
<author></author>
<title>Mol. Brain Res.</title>
</host>
<title>Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum</title>
</json:item>
<json:item><author><json:item><name>M. Pritzel</name>
</json:item>
<json:item><name>J. P. Huston</name>
</json:item>
<json:item><name>M. Sarter</name>
</json:item>
</author>
<host><volume>9</volume>
<pages><last>888</last>
<first>879</first>
</pages>
<author></author>
<title>Neuroscience</title>
</host>
<title>Behavioral and neuronal reorganization after unilateral substantia nigra lesions: Evidence for increased interhemispheric nigrostriatal projections</title>
</json:item>
<json:item><author><json:item><name>Y. Masuo</name>
</json:item>
<json:item><name>M. N. Montagne</name>
</json:item>
<json:item><name>D. Pelaprat</name>
</json:item>
<json:item><name>D. Scherman</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
</author>
<host><volume>520</volume>
<pages><last>13</last>
<first>6</first>
</pages>
<author></author>
<title>Effects of unilateral lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density. Brain Res.</title>
</host>
<title>Regulation of neurotensin‐containing neurons in the rat striatum</title>
</json:item>
<json:item><author><json:item><name>P. A. Lapchak</name>
</json:item>
<json:item><name>D. M. Aranjo</name>
</json:item>
<json:item><name>R. Quirion</name>
</json:item>
<json:item><name>A. Beaudet</name>
</json:item>
</author>
<host><volume>56</volume>
<pages><last>657</last>
<first>651</first>
</pages>
<author></author>
<title>J. Neurochem.</title>
</host>
<title>Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone</title>
</json:item>
<json:item><author><json:item><name>C. M. Waters</name>
</json:item>
<json:item><name>S. P. Hunt</name>
</json:item>
<json:item><name>P. Jeanner</name>
</json:item>
<json:item><name>C. D. Marsden</name>
</json:item>
</author>
<host><volume>412</volume>
<pages><last>253</last>
<first>244</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Localization of neurotensin receptors in the forebrain of the common marmoset and the effects of treatment with the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine</title>
</json:item>
<json:item><author><json:item><name>M. J. Brownstein</name>
</json:item>
<json:item><name>E. P. Mroz</name>
</json:item>
<json:item><name>M. L. Tappaz</name>
</json:item>
<json:item><name>S. E. Leeman</name>
</json:item>
</author>
<host><volume>135</volume>
<pages><last>323</last>
<first>315</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>On the origin of substance P and GAD in the substantia nigra</title>
</json:item>
<json:item><author><json:item><name>R. Schwarcz</name>
</json:item>
<json:item><name>I. Shoulson</name>
</json:item>
</author>
<host><pages><last>68</last>
<first>39</first>
</pages>
<author></author>
<title>Animal Models of Dementia</title>
</host>
<title>Excitotoxins and Huntington's disease</title>
</json:item>
<json:item><author><json:item><name>N. W. Kowall</name>
</json:item>
<json:item><name>R. J. Ferrante</name>
</json:item>
<json:item><name>J. B. Martin</name>
</json:item>
</author>
<host><volume>10</volume>
<pages><last>29</last>
<first>24</first>
</pages>
<author></author>
<title>TINS</title>
</host>
<title>Pattern of cell loss in Huntington's disease</title>
</json:item>
<json:item><author><json:item><name>J. L. Sadoul</name>
</json:item>
<json:item><name>F. Checler</name>
</json:item>
<json:item><name>P. Kitabgi</name>
</json:item>
<json:item><name>W. Rostène</name>
</json:item>
<json:item><name>F. Javoy‐Agid</name>
</json:item>
<json:item><name>J. P. Vincent</name>
</json:item>
</author>
<host><volume>125</volume>
<pages><last>404</last>
<first>395</first>
</pages>
<author></author>
<title>Biochem. Biophys. Res. Commun.</title>
</host>
<title>Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects</title>
</json:item>
<json:item><author><json:item><name>G. R. Uhl</name>
</json:item>
<json:item><name>P. J. Whitehouse</name>
</json:item>
<json:item><name>D. L. Price</name>
</json:item>
<json:item><name>W. W. Tourtelotte</name>
</json:item>
<json:item><name>M. J. Kuhar</name>
</json:item>
</author>
<host><volume>308</volume>
<pages><last>190</last>
<first>186</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Parkinson's disease: Depletion of substantia nigra neurotensin receptors</title>
</json:item>
<json:item><host><author></author>
<title>Changes in opioid, neurotensin receptor density and neutral endopeptidase in Parkinson and Huntington brains18th Neuroscience Meeting</title>
</host>
</json:item>
<json:item><author><json:item><name>C. B. Nemeroff</name>
</json:item>
<json:item><name>W. W. Youngblood</name>
</json:item>
<json:item><name>P. J. Manberg</name>
</json:item>
<json:item><name>A. J. Prange Jr.</name>
</json:item>
<json:item><name>J. S. Kizer</name>
</json:item>
</author>
<host><volume>221</volume>
<pages><last>975</last>
<first>972</first>
</pages>
<author></author>
<title>Science</title>
</host>
<title>Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia</title>
</json:item>
<json:item><author><json:item><name>J. M. Palacios</name>
</json:item>
<json:item><name>G. Chinaglia</name>
</json:item>
<json:item><name>M. Rigo</name>
</json:item>
<json:item><name>J. Wrich</name>
</json:item>
<json:item><name>A. Probst</name>
</json:item>
</author>
<host><volume>7</volume>
<pages><last>122</last>
<first>114</first>
</pages>
<author></author>
<title>Synapse</title>
</host>
<title>Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia</title>
</json:item>
<json:item><author><json:item><name>G. Bissette</name>
</json:item>
<json:item><name>B. Levant</name>
</json:item>
<json:item><name>C. B. Nemeroff</name>
</json:item>
</author>
<host><pages><last>556</last>
<first>549</first>
</pages>
<author></author>
<title>Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission</title>
</host>
<title>Neurotensin and its possible significance in the pathophysiology of schizophrenia</title>
</json:item>
<json:item><author><json:item><name>W. C. Benzing</name>
</json:item>
<json:item><name>E. J. Mufson</name>
</json:item>
<json:item><name>L. Jennes</name>
</json:item>
<json:item><name>D. M. Amstrong</name>
</json:item>
</author>
<host><volume>537</volume>
<pages><last>302</last>
<first>298</first>
</pages>
<author></author>
<title>Brain Res.</title>
</host>
<title>Reduction of neurotensin immunoreactivity in the amygdala in Alzheimer's disease</title>
</json:item>
<json:item><author><json:item><name>K. L. R. Jansen</name>
</json:item>
<json:item><name>R. L. M. Faull</name>
</json:item>
<json:item><name>M. Dragunow</name>
</json:item>
<json:item><name>G. L. Synek</name>
</json:item>
</author>
<host><volume>39</volume>
<pages><last>627</last>
<first>613</first>
</pages>
<author></author>
<title>An autoradiographic study. Neuroscience</title>
</host>
<title>Alzheimer's disease: Changes in hippocampal NMDA, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors</title>
</json:item>
</refBibs>
<genre><json:string>article</json:string>
</genre>
<host><volume>668</volume>
<publisherId><json:string>NYAS</json:string>
</publisherId>
<pages><total>15</total>
<last>231</last>
<first>217</first>
</pages>
<issn><json:string>0077-8923</json:string>
</issn>
<issue>1</issue>
<genre><json:string>journal</json:string>
</genre>
<language><json:string>unknown</json:string>
</language>
<eissn><json:string>1749-6632</json:string>
</eissn>
<title>Annals of the New York Academy of Sciences</title>
<doi><json:string>10.1111/(ISSN)1749-6632</json:string>
</doi>
</host>
<categories><wos><json:string>science</json:string>
<json:string>multidisciplinary sciences</json:string>
</wos>
<scienceMetrix><json:string>general</json:string>
<json:string>general science & technology</json:string>
<json:string>general science & technology</json:string>
</scienceMetrix>
</categories>
<publicationDate>1992</publicationDate>
<copyrightDate>1992</copyrightDate>
<doi><json:string>10.1111/j.1749-6632.1992.tb27352.x</json:string>
</doi>
<id>135BE6F1E74ADD9674480F68A24875253FBBEC94</id>
<score>0.19446518</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/135BE6F1E74ADD9674480F68A24875253FBBEC94/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/135BE6F1E74ADD9674480F68A24875253FBBEC94/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/135BE6F1E74ADD9674480F68A24875253FBBEC94/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Interaction between Neurotensin and Dopamine in the Brain</title>
<title level="a" type="sub" xml:lang="en">Morphofunctional and Clinical Evidence</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<availability><p>WILEY</p>
</availability>
<date>1992</date>
</publicationStmt>
<notesStmt><note type="content">*This work was supported by INSERM, the Ministère de la Recherche et de la Technologie (MRT fellowship to A.B.), ARC (fellowship to C.D.), and by the Canon Foundation (fellowship to Y.M.).</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Interaction between Neurotensin and Dopamine in the Brain</title>
<title level="a" type="sub" xml:lang="en">Morphofunctional and Clinical Evidence</title>
<author xml:id="author-1"><persName><forename type="first">WILLIAM</forename>
<surname>ROSTÈNE</surname>
</persName>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<affiliation>Address for correspondence: INSERM U.339, Hǒpital Saint‐antoine, 184, rue du Fg. St. Antoine, 75571 Paris Cedex 12, France.</affiliation>
</author>
<author xml:id="author-2"><persName><forename type="first">ALINE</forename>
<surname>BROUARD</surname>
</persName>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
</author>
<author xml:id="author-3"><persName><forename type="first">CORINNE</forename>
<surname>DANA</surname>
</persName>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
</author>
<author xml:id="author-4"><persName><forename type="first">YOSHINORI</forename>
<surname>MASUO</surname>
</persName>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
</author>
<author xml:id="author-5"><persName><forename type="first">FRANCE</forename>
<surname>AGID</surname>
</persName>
<affiliation>INSERM U.289, Hǒpital de la Salpétrière, 75651 Paris Cedex 13, France</affiliation>
</author>
<author xml:id="author-6"><persName><forename type="first">MICHELINE</forename>
<surname>VIAL</surname>
</persName>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
</author>
<author xml:id="author-7"><persName><forename type="first">ANNE‐MARIE</forename>
<surname>LHIAUBET</surname>
</persName>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
</author>
<author xml:id="author-8"><persName><forename type="first">DIDIER</forename>
<surname>PELAPRAT</surname>
</persName>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
</author>
</analytic>
<monogr><title level="j">Annals of the New York Academy of Sciences</title>
<idno type="pISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<idno type="DOI">10.1111/(ISSN)1749-6632</idno>
<imprint><publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1992-10"></date>
<biblScope unit="volume">668</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="217">217</biblScope>
<biblScope unit="page" to="231">231</biblScope>
</imprint>
</monogr>
<idno type="istex">135BE6F1E74ADD9674480F68A24875253FBBEC94</idno>
<idno type="DOI">10.1111/j.1749-6632.1992.tb27352.x</idno>
<idno type="ArticleID">NYAS217</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1992</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
<revisionDesc><change when="1992-10">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/135BE6F1E74ADD9674480F68A24875253FBBEC94/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1749-6632</doi>
<issn type="print">0077-8923</issn>
<issn type="electronic">1749-6632</issn>
<idGroup><id type="product" value="NYAS"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup><title type="main" sort="ANNALS OF NEW YORK ACADEMY SCIENCES">Annals of the New York Academy of Sciences</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="10001"><doi origin="wiley">10.1111/nyas.1992.668.issue-1</doi>
<titleGroup><title type="main">The Neurobiology of Neurotensin</title>
</titleGroup>
<numberingGroup><numbering type="journalVolume" number="668">668</numbering>
<numbering type="journalIssue">1</numbering>
</numberingGroup>
<coverDate startDate="1992-10">October 1992</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="20" status="forIssue"><doi origin="wiley">10.1111/j.1749-6632.1992.tb27352.x</doi>
<idGroup><id type="unit" value="NYAS217"></id>
</idGroup>
<countGroup><count type="pageTotal" number="15"></count>
</countGroup>
<titleGroup><title type="tocHeading1">Part IV. Neurotensin‐Dopamine Interactions</title>
</titleGroup>
<eventGroup><event type="firstOnline" date="2006-12-17"></event>
<event type="publishedOnlineFinalForm" date="2006-12-17"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-21"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-19"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst" number="217">217</numbering>
<numbering type="pageLast" number="231">231</numbering>
</numberingGroup>
<correspondenceTo>Address for correspondence: INSERM U.339, Hǒpital Saint‐antoine, 184, rue du Fg. St. Antoine, 75571 Paris Cedex 12, France.</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:NYAS.NYAS217.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="referenceTotal" number="71"></count>
<count type="linksCrossRef" number="10"></count>
</countGroup>
<titleGroup><title type="main">Interaction between Neurotensin and Dopamine in the Brain</title>
<title type="subtitle">Morphofunctional and Clinical Evidence<link href="#fn1">a</link>
</title>
</titleGroup>
<creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>WILLIAM</givenNames>
<familyName>ROSTÈNE</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>ALINE</givenNames>
<familyName>BROUARD</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>CORINNE</givenNames>
<familyName>DANA</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr4" affiliationRef="#a1"><personName><givenNames>YOSHINORI</givenNames>
<familyName>MASUO</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr5" affiliationRef="#a2"><personName><givenNames>FRANCE</givenNames>
<familyName>AGID</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr6" affiliationRef="#a1"><personName><givenNames>MICHELINE</givenNames>
<familyName>VIAL</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr7" affiliationRef="#a1"><personName><givenNames>ANNE‐MARIE</givenNames>
<familyName>LHIAUBET</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr8" affiliationRef="#a1"><personName><givenNames>DIDIER</givenNames>
<familyName>PELAPRAT</familyName>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="a1" countryCode="FR"><unparsedAffiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a2" countryCode="FR"><unparsedAffiliation>INSERM U.289, Hǒpital de la Salpétrière, 75651 Paris Cedex 13, France</unparsedAffiliation>
</affiliation>
</affiliationGroup>
</contentMeta>
<noteGroup><note xml:id="fn1"><label>a</label>
<p>This work was supported by INSERM, the Ministère de la Recherche et de la Technologie (MRT fellowship to A.B.), ARC (fellowship to C.D.), and by the Canon Foundation (fellowship to Y.M.).</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Interaction between Neurotensin and Dopamine in the Brain</title>
<subTitle>Morphofunctional and Clinical Evidence</subTitle>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Interaction between Neurotensin and Dopamine in the Brain</title>
</titleInfo>
<name type="personal"><namePart type="given">WILLIAM</namePart>
<namePart type="family">ROSTÈNE</namePart>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<affiliation>Address for correspondence: INSERM U.339, Hǒpital Saint‐antoine, 184, rue du Fg. St. Antoine, 75571 Paris Cedex 12, France.</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ALINE</namePart>
<namePart type="family">BROUARD</namePart>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">CORINNE</namePart>
<namePart type="family">DANA</namePart>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">YOSHINORI</namePart>
<namePart type="family">MASUO</namePart>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">FRANCE</namePart>
<namePart type="family">AGID</namePart>
<affiliation>INSERM U.289, Hǒpital de la Salpétrière, 75651 Paris Cedex 13, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">MICHELINE</namePart>
<namePart type="family">VIAL</namePart>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">ANNE‐MARIE</namePart>
<namePart type="family">LHIAUBET</namePart>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">DIDIER</namePart>
<namePart type="family">PELAPRAT</namePart>
<affiliation>INSERM U.339, Hǒpital Saint‐Antoine, 75571 Paris Cedex 12, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo><publisher>Blackwell Publishing Ltd</publisher>
<place><placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1992-10</dateIssued>
<copyrightDate encoding="w3cdtf">1992</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="references">71</extent>
</physicalDescription>
<note type="content">*This work was supported by INSERM, the Ministère de la Recherche et de la Technologie (MRT fellowship to A.B.), ARC (fellowship to C.D.), and by the Canon Foundation (fellowship to Y.M.).</note>
<relatedItem type="host"><titleInfo><title>Annals of the New York Academy of Sciences</title>
</titleInfo>
<genre type="journal">journal</genre>
<identifier type="ISSN">0077-8923</identifier>
<identifier type="eISSN">1749-6632</identifier>
<identifier type="DOI">10.1111/(ISSN)1749-6632</identifier>
<identifier type="PublisherID">NYAS</identifier>
<part><date>1992</date>
<detail type="title"><title>The Neurobiology of Neurotensin</title>
</detail>
<detail type="volume"><caption>vol.</caption>
<number>668</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>217</start>
<end>231</end>
<total>15</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">135BE6F1E74ADD9674480F68A24875253FBBEC94</identifier>
<identifier type="DOI">10.1111/j.1749-6632.1992.tb27352.x</identifier>
<identifier type="ArticleID">NYAS217</identifier>
<recordInfo><recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Publishing Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B50 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B50 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:135BE6F1E74ADD9674480F68A24875253FBBEC94 |texte= Interaction between Neurotensin and Dopamine in the Brain }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |